Concepedia

Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease

Malek Yaghoubi, Sattar Jafari, Behnam Sajedi, Sepehr Gohari, Samira Akbarieh, Amir Hossein Heydari, Maryam Jameshoorani

European Journal of Gastroenterology & Hepatology · 2017 · 42 citations · 14 references

DOI

Abstract

This study showed beneficial effects of fenofibrate and pioglitazone in patients with fatty liver. Further studies with larger study populations on the effects of these drugs on fatty liver, lipid profile, blood glucose, and insulin are suggested.

References

14

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine · 2010 · 3.2K citations · Full text

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients

Giovanni Targher, Lorenzo Bertolini, Roberto Padovani et al. · Diabetes Care · 2007 · 985 citations · Full text

A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

Elisabetta Bugianesi, E. Gentilcore, Rita Manini et al. · The American Journal of Gastroenterology · 2005 · 685 citations

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study

Mary Ann Huang, Joel K. Greenson, Cewin Chao et al. · The American Journal of Gastroenterology · 2005 · 446 citations · Full text